Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,878 public trials 2,286 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Completed

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

NCT01560403

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Scripps Clinic & Research Foundation La Jolla, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Mount Sinai Medical Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

NCT02682381

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Children's Hospital Los Angeles - RHU Los Angeles, California, United States
  • UCLA Dept. of Medicine Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Georgetown Children's Research Network Washington D.C., District of Columbia, United States
View all 27 locations
View Trial Details
Completed

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

NCT01952080

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +5 more
Locations
  • Children´s Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Mattel Children's Hospital UCLA, Department of Pediatric Gastroenterology Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis

NCT01124149

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Birmingham Gastroenterology Associates, PC Birmingham, Alabama, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Digestive & Liver Disease Specialists Garden Grove, California, United States
  • Long Beach VA Medical Center Long Beach, California, United States
View all 105 locations
View Trial Details
Completed

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

NCT02093663

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +16 more
Locations
  • University of Maryland Children's Hospital Baltimore, Maryland, United States
  • John Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Newton Wellesley Hospital Newton, Massachusetts, United States
View all 33 locations
View Trial Details
Completed

Dietary Treatment of Crohn's Disease

NCT00343642

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +5 more
Locations
  • Gastroenterology Associates of Central Georgia Macon, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

NCT02340819

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +5 more
Locations
  • Tohoku University Hospital Sendai, Aoba-ku, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Hodogaya-ku, Japan
  • Hospital of Hyogo College of Medicine Hyōgo, Nishinomiya, Japan
  • Osaka University Hospital, Department of Gastroenterological Surgery Osaka, Suita, Japan
View Trial Details
Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

NCT00081458

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern Center for Clinical Research Chicago, Illinois, United States
View all 32 locations
View Trial Details
Completed

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

NCT01483144

Conditions
Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +17 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 17 locations
View Trial Details

Related conditions